Abu-Elmagd K et al. |
Hepatic and intestinal transplantation at the University of Pittsburgh. |
1998 |
Clin Transpl |
pmid:10503105
|
Yoshimura R et al. |
The effect of immunosuppressive agents (FK-506, rapamycin) on renal P450 systems in rat models. |
1999 |
J. Pharm. Pharmacol. |
pmid:10504034
|
Linder MW and Elin RJ |
Implications of methodologic bias for therapeutic drug monitoring. |
1999 |
Arch. Pathol. Lab. Med. |
pmid:10506447
|
Letko E et al. |
Tacrolimus (FK 506). |
1999 |
Ann. Allergy Asthma Immunol. |
pmid:10507260
|
Cacciarelli TV et al. |
An analysis of pretransplantation variables associated with long-term allograft outcome in pediatric liver transplant recipients receiving primary tacrolimus (FK506) therapy. |
1999 |
Transplantation |
pmid:10507484
|
Cao Z et al. |
Comparison of tacrolimus concentrations measured by the IMx tacrolimus II vs the PRO-TRAC II FK506 ELISA assays. |
1999 |
Clin. Chem. |
pmid:10508139
|
Tredger JM et al. |
Performance of the IMx tacrolimus II assay and practical limits of detection. |
1999 |
Clin. Chem. |
pmid:10508145
|
Chautan M et al. |
Interdigital cell death can occur through a necrotic and caspase-independent pathway. |
1999 |
Curr. Biol. |
pmid:10508592
|
Sche PP et al. |
Display cloning: functional identification of natural product receptors using cDNA-phage display. |
1999 |
Chem. Biol. |
pmid:10508685
|
Lee WP and Mathes DW |
Hand transplantation: pertinent data and future outlook. |
1999 |
J Hand Surg Am |
pmid:10509267
|
Böttiger Y et al. |
Tacrolimus whole blood concentrations correlate closely to side-effects in renal transplant recipients. |
1999 |
Br J Clin Pharmacol |
pmid:10510159
|
Dusting GJ et al. |
Cyclosporin A and tacrolimus (FK506) suppress expression of inducible nitric oxide synthase in vitro by different mechanisms. |
1999 |
Br. J. Pharmacol. |
pmid:10510443
|
Robinson BV et al. |
Optimal dosing of intravenous tacrolimus following pediatric heart transplantation. |
1999 |
J. Heart Lung Transplant. |
pmid:10512526
|
Rostaing L et al. |
Differences in Type 1 and Type 2 intracytoplasmic cytokines, detected by flow cytometry, according to immunosuppression (cyclosporine A vs. tacrolimus) in stable renal allograft recipients. |
1999 |
Clin Transplant |
pmid:10515221
|
Charney DA et al. |
Plasma cell-rich acute renal allograft rejection. |
1999 |
Transplantation |
pmid:10515379
|
Fan L et al. |
Improved artificial death switches based on caspases and FADD. |
1999 |
Hum. Gene Ther. |
pmid:10515447
|
Cunningham EB |
An inositolphosphate-binding immunophilin, IPBP12. |
1999 |
Blood |
pmid:10515881
|
Cardenas ME et al. |
Antifungal activities of antineoplastic agents: Saccharomyces cerevisiae as a model system to study drug action. |
1999 |
Clin. Microbiol. Rev. |
pmid:10515904
|
Moore JM |
NMR techniques for characterization of ligand binding: utility for lead generation and optimization in drug discovery. |
1999 |
Biopolymers |
pmid:10516573
|
Przepiorka D et al. |
Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after HLA-mismatched marrow or blood stem cell transplantation. |
1999 |
Bone Marrow Transplant. |
pmid:10516680
|
Bekersky I et al. |
Bioequivalence of 1 and 5 mg tacrolimus capsules using a replicate study design. |
1999 |
J Clin Pharmacol |
pmid:10516937
|
Pacocha SE et al. |
Regulation of antigen-induced human T-lymphocyte responses by calcineurin antagonists. |
1999 |
J. Allergy Clin. Immunol. |
pmid:10518828
|
Yoshimoto T and Siesjö BK |
Posttreatment with the immunosuppressant cyclosporin A in transient focal ischemia. |
1999 |
Brain Res. |
pmid:10519051
|
Hübner GI et al. |
Drug interaction between mycophenolate mofetil and tacrolimus detectable within therapeutic mycophenolic acid monitoring in renal transplant patients. |
1999 |
Ther Drug Monit |
pmid:10519451
|
Mao Z and Wiedmann M |
Calcineurin enhances MEF2 DNA binding activity in calcium-dependent survival of cerebellar granule neurons. |
1999 |
J. Biol. Chem. |
pmid:10521511
|
Lee SF et al. |
Cytokine receptor common beta chain as a potential activator of cytokine withdrawal-induced apoptosis. |
1999 |
Mol. Cell. Biol. |
pmid:10523628
|
Shadidy M et al. |
Biochemical analysis of mouse FKBP60, a novel member of the FKPB family. |
1999 |
Biochim. Biophys. Acta |
pmid:10524204
|
Grimbert P et al. |
Tacrolimus (FK506)-induced severe and late encephalopathy in a renal transplant recipient. |
1999 |
Nephrol. Dial. Transplant. |
pmid:10528682
|
Cannon RD et al. |
Clinical efficacy of the Abbott Tacrolimus II assay for the IMx. |
1999 Oct-Dec |
Ann. Clin. Lab. Sci. |
pmid:10528829
|
Morita H et al. |
Immunosuppressive effect of leukotriene B(4) receptor antagonist in vitro. |
1999 |
Biochem. Biophys. Res. Commun. |
pmid:10529362
|
Okada M et al. |
Successful treatment of chronic graft-versus-host disease with sulfasalazine in allogeneic bone marrow transplantation. |
1999 |
Acta Haematol. |
pmid:10529517
|
Minematsu T et al. |
Sustained QT prolongation induced by tacrolimus in guinea pigs. |
1999 |
Life Sci. |
pmid:10530807
|
Morris-Stiff G et al. |
Immunosuppression in renal transplantation. Meta-analysis should not have included one of the studies. |
1999 |
BMJ |
pmid:10531121
|
Ellis D et al. |
Epstein-Barr virus-related disorders in children undergoing renal transplantation with tacrolimus-based immunosuppression. |
1999 |
Transplantation |
pmid:10532541
|
Migita K et al. |
FK506 markedly enhances apoptosis of antigen-stimulated peripheral T cells by down-regulation of Bcl-xL. |
1999 |
Transplantation |
pmid:10532544
|
Leroy-Matheron C et al. |
Inhibitor against coagulation factor V after liver transplantation. |
1999 |
Transplantation |
pmid:10532550
|
MistrÃková J et al. |
Increased neoplasm development due to immunosuppressive treatment with FK-506 in BALB/C mice persistently infected with the mouse herpesvirus (MHV-72). |
1999 |
Viral Immunol. |
pmid:10532652
|
Capone D et al. |
Effects of itraconazole on tacrolimus blood concentrations in a renal transplant recipient. |
1999 |
Ann Pharmacother |
pmid:10534229
|
Matsuda J |
[Tacrolimus hydrate (tacrolimus)]. |
1999 |
Nippon Rinsho |
pmid:10543146
|
Aoki Y and Kao PN |
Erythromycin inhibits transcriptional activation of NF-kappaB, but not NFAT, through calcineurin-independent signaling in T cells. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10543746
|
Pearlman DA |
Free energy grids: a practical qualitative application of free energy perturbation to ligand design using the OWFEG method. |
1999 |
J. Med. Chem. |
pmid:10543875
|
Wiedeman PE et al. |
Retention of immunosuppressant activity in an ascomycin analogue lacking a hydrogen-bonding interaction with FKBP12. |
1999 |
J. Med. Chem. |
pmid:10543889
|
Himukai R et al. |
Relationship between the subcellular localization and structures of catalytic domains of FKBP-type PPIases. |
1999 |
J. Biochem. |
pmid:10544281
|
Klein A |
Tacrolimus rescue in liver transplant patients with refractory rejection or intolerance or malabsorption of cyclosporine. The US Multicenter FK506 Liver Study Group. |
1999 |
Liver Transpl Surg |
pmid:10545538
|
Dubernard JM et al. |
[The first transplantation of a hand in humans. Early results]. |
1999 |
Chirurgie |
pmid:10546388
|
Ocran KW et al. |
Tacrolimus toxicity due to drug interaction with mibefradil in a patient after liver transplantation. |
1999 |
Z Gastroenterol |
pmid:10549098
|
Rolles K et al. |
A pilot study of immunosuppressive monotherapy in liver transplantation: tacrolimus versus microemulsified cyclosporin. |
1999 |
Transplantation |
pmid:10551650
|
Pirsch JD |
Cytomegalovirus infection and posttransplant lymphoproliferative disease in renal transplant recipients: results of the U.S. multicenter FK506 Kidney Transplant Study Group. |
1999 |
Transplantation |
pmid:10551653
|
Zoppo A et al. |
Trimetazidine counteracts tacrolimus nephrotoxicity in a hypertensive liver transplant patient. |
1999 |
Transplantation |
pmid:10551656
|
Chen L et al. |
Bastadin 10 stabilizes the open conformation of the ryanodine-sensitive Ca(2+) channel in an FKBP12-dependent manner. |
1999 |
J. Biol. Chem. |
pmid:10551814
|